Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)

Showing 121 - 130 of 183 results

First page
Previous page
Next page
Next page

LEXATUMUMAB

967Q0SJD77

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT00428272: Phase 1 Interventional Terminated Ewing's Sarcoma

(2006)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00428272

Class:

PROTEIN

ABAGOVOMAB

3YK0326U7X

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT00103545: Phase 1/Phase 2 Interventional Completed Ovarian Cancer

(2003)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00103545

Class:

PROTEIN

GANITUMAB

CK1441RCZ8

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT02306161: Phase 3 Interventional Active, not recruiting Metastatic Ewing Sarcoma

(2014)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02306161

Class:

PROTEIN

RACOTUMOMAB

52G405U1E5

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT02998983: Phase 2 Interventional Completed Neuroblastoma

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02998983

Class:

PROTEIN

SOFITUZUMAB

910KH73X8Q

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

USAN:SOFITUZUMAB [USAN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/910KH73X8Q

Class:

PROTEIN

RILOTUMUMAB

51WEW898IJ

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT02137343: Phase 3 Interventional Terminated Gastric Cancer

(2014)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02137343

Class:

PROTEIN

DACETUZUMAB

UT59FF4T5X

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT00435916: Phase 2 Interventional Completed Lymphoma, Large B-Cell, Diffuse

(2006)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00435916

Class:

PROTEIN

LUCATUMUMAB

P0EP9VFC4R

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT00670592: Phase 1/Phase 2 Interventional Completed Non-Hodgkin's Lymphoma

(2008)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00670592

Class:

PROTEIN

ZANOLIMUMAB

HG3L8885M0

Sequence Search

Status:

Investigational

Source:

NCT00877656: Phase 2/Phase 3 Interventional Completed T Cell Lymphoma

(2005)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00877656

Class:

PROTEIN

BAVITUXIMAB

Q16CT95N25

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT04150900: Phase 2 Interventional Active, not recruiting Squamous Cell Carcinoma

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04150900

Class:

PROTEIN

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Showing 121 - 130 of 183 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1